Sign Up Today and Learn More About Hemotune Stock
Invest in or calculate the value of your shares in Hemotune or other pre-IPO companies through EquityZen's platform.
Hemotune Stock (HEMO)
Hemotune is a medical device company that develops a therapeutic blood purification platform for treatment of health ailments.
About Hemotune Stock
Founded
2016
Industries
Software, Artificial Intelligence, Data and Analytics
Hemotune Press Mentions
Stay in the know about the latest news on Hemotune
Assembly for extracorporeal treatment of body fluids
patents • Apr 14, 2024
Hemotune AG. (3/25/24). "Press Release: Hemotune Raises CHF 14 Million Series B2 Funding for Clinical Trials with the HemoSystem". Schlieren.
life-sciences-germany • Apr 07, 2024
CHF 14 million to fund hemotune’s clinical trials
startupticker • Mar 26, 2024
AstraZeneca enters close collaboration with hemotune
startupticker • Mar 24, 2023
hemotune raises CHF 5.1 million Series A funding
hemotune • Aug 17, 2022
Hemotune Management
Leadership team at Hemotune
CEO and Co-Founder
Lukas Langenegger
CSO and Co-Founder
Carlos Mora
Join now and verify your accreditation status to gain access to:
- Hemotune Current Valuation
- Hemotune Stock Price
- Hemotune Management
- Available deals in Hemotune and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Hemotune Cap Table and Funding History by Share Class and Liquidity Preferences
- Hemotune Revenue and Financials
- Hemotune Highlights
- Hemotune Business Model
- Hemotune Risk Factors
- Hemotune Research Report from SACRA Research
Trading Hemotune Stock
How to invest in Hemotune stock?
Accredited investors can buy pre-IPO stock in companies like Hemotune through EquityZen funds. These investments are made available by existing Hemotune shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Hemotune stock?
Shareholders can sell their Hemotune stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
